Graziano Oldani1, Lindsey A Crowe2, Lorenzo A Orci3, Florence Slits3, Laura Rubbia-Brandt4, Claudio de Vito4, Philippe Morel3, Gilles Mentha3, Thierry Berney3, Jean-Paul Vallée2, Stéphanie Lacotte3, Christian Toso5. 1. Divisions of Transplant and Abdominal Surgery, Department of Surgery, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland; Department of Surgery, University of Pavia, Italy. 2. Division of Radiology, Department of Medical Imaging, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland. 3. Divisions of Transplant and Abdominal Surgery, Department of Surgery, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland. 4. Division of Clinical Pathology, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland. 5. Divisions of Transplant and Abdominal Surgery, Department of Surgery, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland. Electronic address: christian.toso@hcuge.ch.
Abstract
BACKGROUND & AIMS: Liver transplantation from marginal donors is associated with ischemia/reperfusion (I/R) lesions, which may increase the risk of post-transplant hepatocellular carcinoma (HCC) recurrence. Graft reperfusion prior to retrieval (as for extracorporeal membrane oxygenation--ECMO) can prevent I/R lesions. The impact of I/R on the risk of cancer recurrence was assessed on a syngeneic Fischer-rat liver transplantation model. METHODS: HCC cells were injected into the vena porta of all recipients at the end of an orthotopic liver transplantation (OLT). Control donors were standard heart-beating, ischemic ones (ISC), underwent 10 min or 30 min inflow liver clamping prior to retrieval, and ischemic/reperfused (ISC/R) donors underwent 2h liver reperfusion after the clamping. RESULTS: I/R lesions were confirmed in the ISC group, with the presence of endothelial and hepatocyte injury, and increased liver function tests. These lesions were in part reversed by the 2h reperfusion in the ISC/R group. HCC growth was higher in the 10 min and 30 min ISC recipients (p = 0.018 and 0.004 vs. control, as assessed by MRI difference between weeks one and two), and was prevented in the ISC/Rs (p = 0.04 and 0.01 vs. ISC). These observations were associated with a stronger pro-inflammatory cytokine profile in the ISC recipients only, and the expression of hypoxia and HCC growth-enhancer genes, including Hmox1, Hif1a and Serpine1. CONCLUSIONS: This experiment suggests that ischemia/reperfusion lesions lead to an increased risk of post-transplant HCC recurrence and growth. This observation can be reversed by graft reperfusion prior to retrieval.
BACKGROUND & AIMS: Liver transplantation from marginal donors is associated with ischemia/reperfusion (I/R) lesions, which may increase the risk of post-transplant hepatocellular carcinoma (HCC) recurrence. Graft reperfusion prior to retrieval (as for extracorporeal membrane oxygenation--ECMO) can prevent I/R lesions. The impact of I/R on the risk of cancer recurrence was assessed on a syngeneic Fischer-rat liver transplantation model. METHODS: HCC cells were injected into the vena porta of all recipients at the end of an orthotopic liver transplantation (OLT). Control donors were standard heart-beating, ischemic ones (ISC), underwent 10 min or 30 min inflow liver clamping prior to retrieval, and ischemic/reperfused (ISC/R) donors underwent 2h liver reperfusion after the clamping. RESULTS: I/R lesions were confirmed in the ISC group, with the presence of endothelial and hepatocyte injury, and increased liver function tests. These lesions were in part reversed by the 2h reperfusion in the ISC/R group. HCC growth was higher in the 10 min and 30 min ISC recipients (p = 0.018 and 0.004 vs. control, as assessed by MRI difference between weeks one and two), and was prevented in the ISC/Rs (p = 0.04 and 0.01 vs. ISC). These observations were associated with a stronger pro-inflammatory cytokine profile in the ISC recipients only, and the expression of hypoxia and HCC growth-enhancer genes, including Hmox1, Hif1a and Serpine1. CONCLUSIONS: This experiment suggests that ischemia/reperfusion lesions lead to an increased risk of post-transplant HCC recurrence and growth. This observation can be reversed by graft reperfusion prior to retrieval.
Authors: Negin Karimian; Alix P M Matton; Andrie C Westerkamp; Laura C Burlage; Sanna Op den Dries; Henri G D Leuvenink; Ton Lisman; Korkut Uygun; James F Markmann; Robert J Porte Journal: J Vis Exp Date: 2015-05-26 Impact factor: 1.355
Authors: Hui Liu; Chang Chun Ling; Wai Ho Oscar Yeung; Li Pang; Jiang Liu; Jie Zhou; Wei Yi Zhang; Xiao Bing Liu; Tak Pan Kevin Ng; Xin Xiang Yang; Chung Mau Lo; Kwan Man Journal: Cell Death Dis Date: 2021-05-14 Impact factor: 8.469
Authors: Graziano Oldani; Andrea Peloso; Florence Slits; Quentin Gex; Vaihere Delaune; Lorenzo A Orci; Yohan van de Looij; Didier J Colin; Stéphane Germain; Claudio de Vito; Laura Rubbia-Brandt; Stéphanie Lacotte; Christian Toso Journal: PLoS One Date: 2019-11-25 Impact factor: 3.240
Authors: Kevin Tak-Pan Ng; Oscar Wai-Ho Yeung; Yin Fan Lam; Jiang Liu; Hui Liu; Li Pang; Xin Xiang Yang; Jiye Zhu; Weiyi Zhang; Matthew Y H Lau; Wen Qi Qiu; Hoi Chung Shiu; Man Kit Lai; Chung Mau Lo; Kwan Man Journal: Cell Death Discov Date: 2021-07-21
Authors: Michał Grąt; Marek Krawczyk; Karolina M Wronka; Jan Stypułkowski; Zbigniew Lewandowski; Michał Wasilewicz; Piotr Krawczyk; Karolina Grąt; Waldemar Patkowski; Krzysztof Zieniewicz Journal: Sci Rep Date: 2018-06-12 Impact factor: 4.379